Share This

Public company info - Pa Shun International Holdings Limited , 00574.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Pa Shun International Holdings Limited, 00574.HK - Company Profile
Chairman Xiao Kai
Share Issued (share) 1,475,000,000
Par Currency Hong Kong Dollar
Par Value 0.001
Industry Medicine
Corporate Profile Business Summary: The principal activities of the Group are pharmaceutical distribution, self-operated retail pharmacies and manufacture of pharmaceutical products in the PRC. Performance for the year: Revenue amounted to approximately RMB474,835,000 (2019: approximately RMB845,448,000). Loss for the year amounted to approximately RMB419,189,000 (2019: approximately RMB193,399,000). Basic and diluted loss per share were RMB28.37 cents (2019: RMB13.38 cents) and N/A (2019: N/A), respectively. Business Review The Group continued to focus on the pharmaceutical distribution and pharmaceutical manufacturing businesses in the PRC during the year ended 31 December 2020. For the selfoperated retail pharmacies business, the Group continued to seek mergers and acquisitions opportunities in respect of established retail pharmacy chains in order to revitalize the business segment. For the year ended 31 December 2020, the Group recorded a total revenue of RMB474.8 million, representing an decrease of approximately 43.8% from RMB845.4 million for last year. This decrease was primarily due to (i) the drop in revenue from the Group’s pharmaceutical distribution to wholesalers due to vigorous competition; and (ii) the outbreak of the novel coronavirus (COVID-19) epidemic (“Epidemic”) that has spread across China and other countries since early 2020 and it has adversely affected the business and economic activities of the Group. The factory of the Group in China was closed or under restricted operation for months during the year ended 31 December 2020. Prospects: Due to the Epidemic in the PRC, the economy of the PRC is seriously affected. Since many economic activities in the PRC are slowed down due to the Epidemic, and the factory of the Group was closed for around two months in the first quarter of 2020, thus the revenue and results of the Group for year ended 31 December 2020 was adversely affected. The Group will continue to leverage on its solid foundation in the PRC and make good use of its existing resources and networks to capture the opportunities to expand to other business through various business development strategies, at the same time diversify its business risk to other investment segments and other countries. In 2019, with the acquisition of two companies which indirectly hold interest in certain units located in the building called “The Apple” which is a multi-storey building located in Melaka, Malaysia, the Group made its first step to explore and invest in the Malaysia property market. Due to the Epidemic and lock down in Malaysia, the construction of the properties were delayed and the time of completion of construction was uncertain yet and may delay to 2023. The Company currently intends to hold the properties for investment purpose to generate rental income for the Group and will engage a local professional property manager to manage the properties and the leasing business upon the completion of construction of the properties. The Company will further seek other similar opportunities to reduce the operation risk of the Group.

Information from the financial statements of listed companies

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.